Literature DB >> 6320196

Identification of thymidine nucleotidase and deoxyribonucleotidase activities among normal isozymes of 5'-nucleotidase in human erythrocytes.

D E Paglia, W N Valentine, R A Brockway.   

Abstract

The persistence of normal thymidine nucleotidase (ThyNase) activity in subjects with pyrimidine nucleotidase (PyrNase) deficiency suggested the possible existence of separate isozymes in normal human erythrocytes. This hypothesis was confirmed by studies of PyrNase-deficient individuals from five unrelated families. Erythrocytes deficient in PyrNase retained normal activity of an enzyme system preferentially active at pH 6.2 with a variety of 2'-deoxyribonucleoside 5'-monophosphate substrates, including those of uridine, thymidine, and cytidine. Lesser activities were observed with the corresponding ribonucleotides. Normal control hemolysates were also found capable of effectively dephosphorylating purine nucleotides (dAMP greater than AMP) when pH was lowered sufficiently from the pH 7.4-8.0 region commonly used in conventional assays. Variations in substrate specificity, pH optima, kinetics, and sensitivity to inactivation by Pb2+ indicated the existence of multiple 5'-nucleotidase isozymes in normal erythrocytes: PyrNase and deoxyribonucleotidase(s) that might function physiologically in the conversion of DNA-derived nucleotides to diffusible nucleosides. Evolution of such a unique 5'-nucleotidase suggests that normal erythroblast maturation and nuclear extrusion is accompanied by a degree of karyolysis sufficient to require dephosphorylation and clearance of DNA degradation products.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6320196      PMCID: PMC344724          DOI: 10.1073/pnas.81.2.588

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  An electron microscopic study of red bone marrow.

Authors:  D C PEASE
Journal:  Blood       Date:  1956-06       Impact factor: 22.113

2.  Hereditary hemolytic anemia with human erythrocyte pyrimidine 5'-nucleotidase deficiency.

Authors:  W N Valentine; K Fink; D E Paglia; S R Harris; W S Adams
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

3.  Studies on the mechanism of denucleation of the erythroblast.

Authors:  M Awai; S Okada; J Takebayashi; T Kubo; M Inoue; S Seno
Journal:  Acta Haematol       Date:  1968-04       Impact factor: 2.195

Review 4.  Hereditary and acquired defects in the pyrimidine nucleotidase of human erythrocytes.

Authors:  D E Paglia; W N Valentine
Journal:  Curr Top Hematol       Date:  1980

5.  Electrophoretic and kinetic studies of human erythrocytes deficient in pyrimidine 5'-nucleotidase.

Authors:  Y Ishida; S Miwa; Y Miura; A Kibe
Journal:  Clin Chim Acta       Date:  1980-12-08       Impact factor: 3.786

6.  Pyrimidine 5'-nucleotidase deficiency: studies of five cases in two Japanese families.

Authors:  Y Ishida; H Fujii; S Miwa
Journal:  Hemoglobin       Date:  1980       Impact factor: 0.849

7.  Pyrimidine nucleotidase deficiency with active dephosphorylation of dTMP: evidence for existence of thymidine nucleotidase in human erythrocytes.

Authors:  D E Paglia; W N Valentine; A S Keitt; R A Brockway; M Nakatani
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

8.  Analysis of human erythrocyte 5'-nucleotidases in healthy individuals and a patient deficient in pyrimidine 5'-nucleotidase.

Authors:  D M Swallow; I Aziz; D A Hopkinson; S Miwa
Journal:  Ann Hum Genet       Date:  1983-01       Impact factor: 1.670

9.  The mechanism of denucleation in circulating erythroblasts.

Authors:  C F Simpson; J M Kling
Journal:  J Cell Biol       Date:  1967-10       Impact factor: 10.539

10.  An electron microscopic study of nuclear elimination from the late erythroblast.

Authors:  E Skutelsky; D Danon
Journal:  J Cell Biol       Date:  1967-06       Impact factor: 10.539

View more
  9 in total

1.  Determination of pyrimidine 5'-nucleotidase (P5N) activity in whole blood as an index of lead exposure.

Authors:  T Sakai; T Araki; K Ushio
Journal:  Br J Ind Med       Date:  1988-06

2.  Conversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes.

Authors:  A De Flora; E Zocchi; L Guida; C Polvani; U Benatti
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

3.  Pyrimidine 5'-nucleotidase activity in normal and deficient human lymphoblastoid cells.

Authors:  D A Hopkinson; D M Swallow; A Marinaki; E H Harley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

4.  A simplified method for determining erythrocyte pyrimidine 5'-nucleotidase (P5N) activity by HPLC and its value in monitoring lead exposure.

Authors:  T Sakai; K Ushio
Journal:  Br J Ind Med       Date:  1986-12

5.  Relationship between inhibition of erythrocyte pyrimidine 5'-nucleotidase activity and biological response for porphyrin metabolism in workers occupationally exposed to lead.

Authors:  K Tomokuni; M Ichiba; Y Hirai; T Hasegawa; K Sugimoto
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

6.  Adenine ribo- and deoxyribonucleotide metabolism in human erythrocytes, B- and T-lymphocyte cell lines, and monocyte-macrophages.

Authors:  W N Valentine; D E Paglia; S Clarke; B H Morimoto; M Nakatani; R Brockway
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

7.  Homogeneous pyrimidine nucleotidase from human erythrocytes: enzymic and molecular properties.

Authors:  A Amici; M Emanuelli; E Ferretti; N Raffaelli; S Ruggieri; G Magni
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

8.  Component analysis and characterization of a nuclear deoxyribonucleotidase.

Authors:  K Ford; J Waltho; D Hornby
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

9.  5'-Nucleotidase activities in human erythrocytes. Identification of a purine 5'-nucleotidase stimulated by ATP and glycerate 2,3-bisphosphate.

Authors:  F Bontemps; G Van den Berghe; H G Hers
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.